The DigniCap Scalp Cooling System has been used around the world since 2001. In 2015, after a multi-center clinical trial, DigniCap became the first scalp cooling system to receive FDA clearance in the United States.
Dignitana is a Swedish medical technology company publicly traded on Nasdaq First North Growth Market. Company headquarters are in Lund, Sweden and operations are based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy.
The company develops, produces and markets The DigniCap Scalp Cooling System. It is a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy to improve well-being and quality of life. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. In 2017, Dignitana received an expanded clearance from the FDA, allowing DigniCap to be used by patients receiving chemotherapy to treat solid tumors from breast cancer as well as those from prostate, ovarian, uterine, lungs and other tissues.
Our mission is to provide cancer patients with dignity and control during a very challenging time. Working directly with both clinicians and patients, we provide an innovative medical device in combination with expertise, education and support throughout the scalp cooling process.
To establish Dignitana as the world leader in scalp cooling.
To make scalp cooling a standard option for cancer care and to make scalp cooling readily accessible for all patients.
10925 Estate Lane, Suite 185
Dallas, TX 75238
226 60 Lund, Sweden
+46 46 16 30 90
Corso di Porta Nuova, 46
20121 Milan, Italy